Celularity Inc. (NASDAQ:CELUW – Get Free Report) saw a significant drop in short interest in May. As of May 29th, there was short interest totaling 10,742 shares, a drop of 55.9% from the May 14th total of 24,342 shares. Based on an average trading volume of 14,702 shares, the short-interest ratio is presently 0.7 days.
Celularity Price Performance
Shares of CELUW traded down $0.00 on Monday, hitting $0.00. 30,810 shares of the stock traded hands, compared to its average volume of 19,834. The business has a 50 day simple moving average of $0.01 and a 200 day simple moving average of $0.01. Celularity has a one year low of $0.00 and a one year high of $0.06.
Celularity Company Profile
Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.
The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.
Recommended Stories
- Five stocks we like better than Celularity
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
- Gold Is Testing Its 200-Day SMA—These 3 Mining Stocks Are the Play
Receive News & Ratings for Celularity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celularity and related companies with MarketBeat.com's FREE daily email newsletter.
